Works matching IS 02683369 AND DT 2012 AND VI 47 AND IP 6

Results: 22

Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 817, doi. 10.1038/bmt.2011.181

By:

Chen, D-F;
Prasad, V K;
Broadwater, G;
Reinsmoen, N L;
DeOliveira, A;
Clark, A;
Sullivan, K M;
Chute, J P;
Horwitz, M E;
Gasparetto, C;
Long, G D;
Yang, Y;
Chao, N J;
Rizzieri, D A

Publication type:

Article

Experimental and applied immunotherapy.

Published in:

2012

By:

Rezvani, K

Publication type:

Book Review

Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptors.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 791, doi. 10.1038/bmt.2011.187

By:

Clausen, J;
Kircher, B;
Auberger, J;
Schumacher, P;
Grabmer, C;
Mühlbacher, A;
Gastl, G;
Nachbaur, D

Publication type:

Article

Infusion of autologous peripheral blood stem cells in an unrelated donor who developed severe aplastic anemia following stem cell donation.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 869, doi. 10.1038/bmt.2011.174

By:

Frangoul, H;
Navarro, W H;
Confer, D L;
Jagasia, M

Publication type:

Article

Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 874, doi. 10.1038/bmt.2011.189

By:

Ianotto, J-C;
Tempescul, A;
Yan, X;
Delepine, P;
Le Calloch, R;
Hardy, E;
Eveillard, J-R;
Mugnier, N;
Berthou, C;
Guillerm, G

Publication type:

Article

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 804, doi. 10.1038/bmt.2011.180

By:

Zimmerman, Z;
Scott, B L;
Gopal, A K;
Sandmaier, B M;
Maloney, D G;
Deeg, H J

Publication type:

Article

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 810, doi. 10.1038/bmt.2011.194

By:

Khoury, H J;
Kukreja, M;
Goldman, J M;
Wang, T;
Halter, J;
Arora, M;
Gupta, V;
Rizzieri, D A;
George, B;
Keating, A;
Gale, R P;
Marks, D I;
McCarthy, P L;
Woolfrey, A;
Szer, J;
Giralt, S A;
Maziarz, R T;
Cortes, J;
Horowitz, M M;
Lee, S J

Publication type:

Article

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 824, doi. 10.1038/bmt.2011.186

By:

Dignan, F L;
Greenblatt, D;
Cox, M;
Cavenagh, J;
Oakervee, H;
Apperley, J F;
Fielding, A K;
Pagliuca, A;
Mufti, G;
Raj, K;
Marks, D I;
Amrolia, P;
Peniket, A;
Medd, P;
Potter, M N;
Shaw, B E;
Scarisbrick, J J

Publication type:

Article

Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 870, doi. 10.1038/bmt.2011.176

By:

Poon, L-M;
Koh, L P

Publication type:

Article

Differences in mothers' and fathers' health-related quality of life after pediatric SCT: a longitudinal study.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 855, doi. 10.1038/bmt.2011.190

By:

Barrera, M;
Atenafu, E;
Doyle, J;
Berlin-Romalis, D;
Hancock, K

Publication type:

Article

Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 757, doi. 10.1038/bmt.2011.130

By:

Braamse, A M J;
Gerrits, M M J G;
van Meijel, B;
Visser, O;
van Oppen, P;
Boenink, A D;
Cuijpers, P;
Huijgens, P C;
Beekman, A T F;
Dekker, J

Publication type:

Article

Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 831, doi. 10.1038/bmt.2011.192

By:

Ringdén, O;
Shrestha, S;
da Silva, G T;
Zhang, M-J;
Dispenzieri, A;
Remberger, M;
Kamble, R;
Freytes, C O;
Gale, R P;
Gibson, J;
Gupta, V;
Holmberg, L;
Lazarus, H;
McCarthy, P;
Meehan, K;
Schouten, H;
Milone, G A;
Lonial, S;
Hari, P N

Publication type:

Article

Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 838, doi. 10.1038/bmt.2011.198

By:

Morecki, S;
Gelfand, Y;
Yacovlev, E;
Eizik, O;
Shabat, Y;
Sagiv, I;
Slavin, S

Publication type:

Article

The EBMT risk score.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 749, doi. 10.1038/bmt.2011.110

By:

Gratwohl, A

Publication type:

Article

Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 872, doi. 10.1038/bmt.2011.183

By:

Chiusolo, P;
Metafuni, E;
Bellesi, S;
Giammarco, S;
Za, T;
Laurenti, L;
Sorà, F;
Leone, G;
Sica, S

Publication type:

Article

Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 867, doi. 10.1038/bmt.2011.173

By:

Vokurka, S;
Koza, V;
Jungova, A;
Navratilova, J;
Svoboda, T;
Jindra, P;
Steinerova, K;
Vyrutova, R

Publication type:

Article

ECIL 3-2009 update guidelines for antifungal management.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 866, doi. 10.1038/bmt.2011.154

By:

Castagna, L;
Bramanti, S;
Sarina, B;
Todisco, E;
Ibatici, A;
Santoro, A

Publication type:

Article

Factors predicting single-unit predominance after double umbilical cord blood transplantation.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 799, doi. 10.1038/bmt.2011.184

By:

Ramirez, P;
Wagner, J E;
DeFor, T E;
Blazar, B R;
Verneris, M R;
Miller, J S;
McKenna, D H;
Weisdorf, D J;
McGlave, P B;
Brunstein, C G

Publication type:

Article

Successful treatment with tandem consolidation using <sup>90</sup>yttrium-ibritumomab tiuxetan (Zevalin) and high-dose therapy with autologous PBSCT in a patient with relapsed mantle cell lymphoma presenting as multiple lymphomatous polyposis.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 877, doi. 10.1038/bmt.2011.193

By:

Han, E J;
Yang, S-A;
Sohn, H-S;
Kim, J I;
Kang, C-S;
Cho, S-G

Publication type:

Article

Apheresis product identification in the transplant center: development of point-of-care protocols for extended blood typing of stem cell apheresis products.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 860, doi. 10.1038/bmt.2011.182

By:

Cummerow, C;
Schwind, P;
Spicher, M;
Spohn, G;
Geisen, C;
Seifried, E;
Bönig, H

Publication type:

Article

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 770, doi. 10.1038/bmt.2011.185

By:

Snowden, J A;
Saccardi, R;
Allez, M;
Ardizzone, S;
Arnold, R;
Cervera, R;
Denton, C;
Hawkey, C;
Labopin, M;
Mancardi, G;
Martin, R;
Moore, J J;
Passweg, J;
Peters, C;
Rabusin, M;
Rovira, M;
van Laar, J M;
Farge, D

Publication type:

Article

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 846, doi. 10.1038/bmt.2011.178

By:

Marchetti, O;
Lamoth, F;
Mikulska, M;
Viscoli, C;
Verweij, P;
Bretagne, S

Publication type:

Article